VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MTG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MTGMGIC Investment Corporation
$28.21$6.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMTGQuarterly Financials

MGIC Investment Corporation (MTG) Quarterly Financials

120+ quarters historyFree accessUpdated daily

MGIC Investment Corporation (MTG) quarterly income statement — complete revenue, gross profit & net income history

MTG Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue297.08M298.65M304.5M304.25M306.23M301.44M306.65M305.28M294.36M283.96M296.5M290.68M283.96M292.25M292.8M293.12M294.62M294.12M295.75M297.85M
Revenue Growth %-2.99%-0.93%-0.7%-0.34%4.03%6.16%3.42%5.02%3.66%-2.84%1.27%-0.83%-3.62%-0.63%-1%-1.59%-1.12%-2.7%-0.09%1.32%
Medical Costs & Claims34.47M31.22M12.76M-1.1M11.25M11.17M-7.52M-16.12M6.56M-6.6M2.73M-15.08M8.92M-27.67M-101.88M-96.08M-16.57M-21.4M24.06M32.19M
Medical Cost Ratio %11.6%10.45%4.19%-0.36%3.67%3.71%-2.45%-5.28%2.23%-2.33%0.92%-5.19%3.14%-9.47%-34.79%-32.78%-5.63%-7.28%8.14%10.81%
Gross Profit262.61M267.43M291.75M305.34M294.99M290.27M314.17M321.4M287.8M290.56M293.78M305.76M275.04M319.93M394.67M389.19M311.19M315.52M271.69M265.66M
Gross Margin %88.4%89.55%95.81%100.36%96.33%96.29%102.45%105.28%97.77%102.33%99.08%105.19%96.86%109.47%134.79%132.78%105.63%107.28%91.86%89.19%
Gross Profit Growth %-10.98%-7.87%-7.14%-5%2.5%-0.1%6.94%5.12%4.64%-9.18%-25.56%-21.44%-11.62%1.4%45.27%46.5%21.74%24.79%7.79%260.54%
Operating Expenses48.11M54.73M56.69M59.25M60.3M55.56M59.87M61.57M67.92M60.71M59.38M63.38M79.44M79.49M80.41M73.3M91.75M96.96M71.95M71.8M
OpEx / Revenue %16.19%18.32%18.62%19.48%19.69%18.43%19.52%20.17%23.07%21.38%20.03%21.8%27.97%27.2%27.46%25.01%31.14%32.97%24.33%24.1%
Depreciation & Amortization0821K900K2.53M2.69M4.03M3.43M4.48M6.49M6.23M9.63M9.18M10.19M11.43M13.3M14.13M15.39M16.19M17.35M15.05M
Combined Ratio %27.8%28.78%22.81%19.11%23.37%22.14%17.07%14.89%25.3%19.06%20.95%16.61%31.12%17.73%-7.33%-7.77%25.52%25.69%32.47%34.91%
Operating Income214.5M212.71M235.06M246.09M234.68M234.71M254.3M259.82M219.88M229.85M234.4M242.38M195.6M240.44M314.27M315.89M219.44M218.56M199.73M193.87M
Operating Margin %72.2%71.22%77.19%80.89%76.63%77.86%82.93%85.11%74.7%80.94%79.05%83.39%68.88%82.27%107.33%107.77%74.48%74.31%67.53%65.09%
Operating Income Growth %-8.6%-9.37%-7.56%-5.29%6.73%2.11%8.49%7.2%12.41%-4.4%-25.41%-23.27%-10.86%10.01%57.34%62.94%15.73%14.9%21.54%1076.17%
EBITDA214.5M213.53M235.96M248.62M237.38M238.74M257.73M264.31M226.37M236.07M244.03M251.56M205.8M251.86M327.57M330.02M234.83M234.75M217.08M208.92M
EBITDA Margin %72.2%71.5%77.49%81.72%77.51%79.2%84.05%86.58%76.9%83.14%82.3%86.54%72.47%86.18%111.88%112.59%79.71%79.82%73.4%70.14%
Interest Expense8.9M7.8M8.91M8.9M8.9M8.9M8.9M8.9M8.9M8.9M9.25M9.38M9.37M9.38M10.3M13.46M14.91M17.37M18.01M18M
Non-Operating Income0-8.9M-8.91M-8.9M-8.9M-8.9M-8.9M-8.9M-8.9M-8.9M-9.25M-9.38M-9.37M-9.38M-10.3M-13.46M-14.91M-17.37M-18.01M-18M
Pretax Income206.83M212.71M235.06M246.09M234.68M234.71M254.3M259.82M219.88M229.85M234.4M242.38M195.6M240.44M314.27M315.89M219.44M218.56M199.73M193.87M
Pretax Margin %69.62%71.22%77.19%80.89%76.63%77.86%82.93%85.11%74.7%80.94%79.05%83.39%68.88%82.27%107.33%107.77%74.48%74.31%67.53%65.09%
Income Tax41.52M43.4M43.97M53.61M49.22M50.01M54.33M55.6M45.78M45.34M51.55M51.33M41.06M48.99M64.64M66.62M44.43M44.63M41.76M40.82M
Effective Tax Rate %20.08%20.4%18.7%21.78%20.97%21.31%21.36%21.4%20.82%19.73%21.99%21.18%20.99%20.38%20.57%21.09%20.25%20.42%20.91%21.05%
Net Income165.3M169.31M191.09M192.48M185.46M184.7M199.97M204.23M174.1M184.5M182.84M191.05M154.55M191.44M249.63M249.27M175.01M173.93M157.98M153.05M
Net Margin %55.64%56.69%62.76%63.27%60.56%61.27%65.21%66.9%59.14%64.98%61.67%65.73%54.42%65.51%85.25%85.04%59.4%59.14%53.42%51.38%
Net Income Growth %-10.87%-8.33%-4.44%-5.75%6.53%0.11%9.37%6.9%12.65%-3.62%-26.75%-23.35%-11.69%10.07%58.01%62.87%16.66%14.86%20.77%989.56%
EPS (Diluted)0.760.750.830.810.750.720.770.770.640.660.640.660.520.640.810.790.540.520.460.44
EPS Growth %1.33%4.17%7.79%5.19%17.19%9.09%20.31%16.67%23.08%3.13%-20.99%-16.46%-3.7%23.08%76.09%79.55%25.58%18.18%21.05%1000%
EPS (Basic)0.760.750.830.810.760.730.770.770.640.670.650.670.530.650.820.810.550.520.470.45
Diluted Shares Outstanding218.19M225.73M231.38M237.97M246.49M255.3M260.83M266.87M273.11M278.95M285.6M289.57M294.71M299.95M307.19M313.55M324.54M338.93M353.56M356.54M